Palnat 125 (Palbociclib 125mg )

Palnat 125, also known as Palbociclib 125mg, is a type of kinase inhibitor that is utilized in the treatment of advanced or metastatic breast cancer in women who have hormone receptor-positive and HER2-negative tumors. To determine which endocrine therapy the patient should receive, it is prescribed in combination with either an aromatase inhibitor or fulvestrant, depending on their medical history.

DOSAGE AND ADMINISTRATION

It is advised to initiate treatment with a daily oral dose of 125mg taken with food for 21 consecutive days, followed by a 7-day interval without treatment. Depending on the individual's safety and tolerability, dosing adjustments may be required.

Palbociclib price in india:

In India, the cost of Palbociclib is just 6% of the price in the United States. Generic Palbociclib is a prescribed medication that contains the identical active ingredient and adheres to the same pharmaceutical regulations as the brand-name medicine.

Palnat 125 (Palbociclib 125mg ) Side Effects：

Palbociclib may cause a range of common side effects, such as fatigue, hair thinning or loss, mouth sores, nausea, vomiting, diarrhea, rash, loss of appetite, abnormalities in liver blood tests, low red blood cell counts, low platelet counts, and low white blood cell counts. Monitoring blood cell counts frequently is crucial since low white blood cell counts can result in severe infections. Healthcare providers may need to interrupt treatment, lower the dosage, or delay the start of a new cycle if necessary. Additionally, Palbociclib may impact male individuals. fertility.

For more Prescribing information，please check the → “FDA Prescribing Information